News-Medical.Net9h
Vanderbilt researchers aim to use AI to develop antibody therapies for any target
An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the closing of ...
Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...
PharmiWeb3d
Meningitis Treatment Market Outlook to Reach USD 2…
The global meningitis treatment industry, valued at USD 150.9 million in 2023, is projected to grow at a CAGR of 4.1% from ...
Advanced Biomed Inc. Announces Pricing of Initial Public Offering
Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, ...
Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD
CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD -- Flexible Dosing and Extended Duration would be Important ...
Syntec Optics to Enable Next-Gen Augmented Reality System
Syntec uses advanced manufacturing techniques to make projection optics that are very precise and small. These optics stay out of the field of view of users who need AR/VR/MR for extended hours in ...